Valuation: QuidelOrtho Corporation

Market Cap 1.09B 961M 894M 820M 1.54B 105B 1.57B 10.62B 4.15B 51.82B 4.11B 4.02B 179B P/E 2026 *
-10x
P/E 2027 * -100x
Enterprise Value 3.46B 3.04B 2.83B 2.6B 4.88B 334B 4.95B 33.59B 13.12B 164B 13B 12.72B 567B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 1.21x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day-3.20%
1 week-7.65%
Current month-8.36%
1 month+31.45%
3 months+38.48%
6 months-42.86%
Current year-43.80%
1 week 15.54
Extreme 15.545
17.38
1 month 13.52
Extreme 13.52
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
89.11
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Operating Officer 57 2024-11-14
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
-3.20%-7.65%-39.04%-81.82% 1.13B
-0.36%-9.20%+14.18%-38.41% 15.63B
-7.90%+5.00%+0.62%+89.29% 1.79B
-1.41%-4.66%-38.14%+11.27% 960M
-3.39%-5.61%-34.57%-55.85% 630M
-2.46%-5.34%-49.25%-59.41% 517M
+1.87%+3.51%+44.64%-52.83% 452M
+1.52%-3.98%-57.01%-61.54% 359M
-4.04%-6.39%+49.24% - 325M
+0.42%-2.86%-3.25%-5.43% 292M
Average -1.90%-4.19%-11.26%-28.30% 2.21B
Weighted average by Cap. -1.26%-7.30%+4.96%-29.23%

Financials

2026 *2027 *
Net sales 2.71B 2.38B 2.21B 2.03B 3.82B 261B 3.88B 26.29B 10.27B 128B 10.17B 9.95B 444B 2.8B 2.46B 2.29B 2.1B 3.94B 270B 4B 27.15B 10.61B 133B 10.51B 10.28B 458B
Net income -156M -137M -127M -117M -219M -15.01B -223M -1.51B -591M -7.38B -585M -572M -25.51B -81.93M -71.96M -66.92M -61.41M -115M -7.89B -117M -795M -310M -3.88B -308M -301M -13.41B
Net Debt 2.37B 2.08B 1.93B 1.78B 3.34B 228B 3.39B 22.98B 8.98B 112B 8.89B 8.7B 388B 2.3B 2.02B 1.88B 1.72B 3.24B 221B 3.29B 22.29B 8.71B 109B 8.63B 8.44B 376B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-24 US$16.05 -3.20% 913,040
26-07-23 US$16.58 -0.60% 806,537
26-07-22 US$16.68 +1.52% 1,257,035
26-07-21 US$16.43 -0.90% 1,274,873
26-07-20 US$16.58 -4.60% 728,919
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
16.05USD
Average target price
20.50USD
Spread / Average Target
+27.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock